Showing results (41-50 of 126) with videos related to
Sort By:
Pageof 13
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 7, 2024
Feasibility of breast conserving surgery alone in HER2-positive exceptional responders to neoadjuvant systemic therapyMelissa P Mitchell, Simona F Shaitelman, Benjamin D Smith, et al.Histopathology|August 11, 2017
Clinicopathological analysis of ATRX, DAXX and NOTCH receptor expression in angiosarcomasGauri Panse, John Sa Chrisinger, Cheuk H Leung, et al.Journal of Cancer|June 17, 2015
Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-NegativeNisreen Elsayegh, Jessica Profato, Angelica M Gutierrez Barrera, et al.Breast Cancer Research and Treatment|August 11, 2023
Clinical outcome and therapeutic impact on neuroendocrine neoplasms of the breast: a national cancer database studyLibo Yang, Heather Lin, Yu Shen, et al.Cancer Medicine|August 29, 2019
Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non-small cell lung cancerBin Shi, Carmen Behrens, Viralkumar Vaghani, et al.Journal of Cancer|July 2, 2019
The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancerJing Ning, Tamer M Fouad, Heather Lin, et al.Cancer Immunology Research|January 18, 2018
TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer ModelsIsmail M Meraz, Mourad Majidi, Xiaobo Cao, et al.Kidney International Reports|January 16, 2026
Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational EvidenceNada Youssef, Masroor Habeeb, Hong Chen, et al.Oncoimmunology|June 9, 2021
Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysisMaen Abdelrahim, Omar Mamlouk, Heather Lin, et al.Journal of the American College of Surgeons|March 1, 2023
Eliminating Breast Surgery for Invasive Cancer with Exceptional Response to Neoadjuvant Systemic Therapy: Prospective Multicenter Clinical Trial Planned Initial Feasibility EndpointHelen M Johnson, Vicente Valero, Wei T Yang, et al.Pageof 13